Biocorrx (BICX)
(Delayed Data from OTC)
$0.75 USD
-0.07 (-8.54%)
Updated Apr 26, 2024 11:36 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Biocorrx Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 4 | 5 | 6 | 8 | 6 |
Income After Depreciation & Amortization | -4 | -5 | -6 | -7 | -6 |
Non-Operating Income | 1 | 1 | 1 | 5 | 1 |
Interest Expense | 1 | 1 | 1 | 1 | 2 |
Pretax Income | -4 | -4 | -5 | -4 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -4 | -5 | -4 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -4 | -5 | -3 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | -4 | -5 | -7 | -4 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -4 | -5 | -6 | -7 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.34 | NA | 6.49 | 5.38 | NA |
Diluted EPS Before Non-Recurring Items | -0.44 | NA | -0.79 | -0.65 | NA |
Diluted Net EPS (GAAP) | -0.45 | -0.61 | -0.81 | -0.65 | -1.71 |
Fiscal Year end for Biocorrx Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.02 | 0.01 | 0.02 | 0.04 |
Cost Of Goods | NA | 0.01 | 0.00 | 0.01 | 0.01 |
Gross Profit | NA | 0.01 | 0.01 | 0.01 | 0.03 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.83 | 0.97 | 0.96 | 1.09 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.82 | -0.96 | -0.95 | -1.06 |
Non-Operating Income | NA | 0.15 | 0.30 | 0.21 | 0.24 |
Interest Expense | NA | 0.29 | 0.21 | 0.19 | 0.20 |
Pretax Income | NA | -0.97 | -0.87 | -0.92 | -1.01 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.97 | -0.87 | -0.92 | -1.01 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.97 | -0.87 | -0.92 | -1.01 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 8.63 | 8.54 | 8.46 | 7.74 |
Diluted EPS Before Non-Recurring Items | NA | -0.11 | -0.10 | -0.11 | -0.12 |
Diluted Net EPS (GAAP) | NA | -0.11 | -0.10 | -0.11 | -0.13 |